 Skin Neoplasms
"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 | | 1997 | 4 | 0 | 4 | | 1998 | 6 | 0 | 6 | | 1999 | 3 | 1 | 4 | | 2000 | 3 | 1 | 4 | | 2001 | 7 | 0 | 7 | | 2002 | 10 | 1 | 11 | | 2003 | 5 | 1 | 6 | | 2004 | 11 | 3 | 14 | | 2005 | 18 | 3 | 21 | | 2006 | 16 | 0 | 16 | | 2007 | 14 | 1 | 15 | | 2008 | 11 | 2 | 13 | | 2009 | 19 | 6 | 25 | | 2010 | 12 | 3 | 15 | | 2011 | 20 | 1 | 21 | | 2012 | 31 | 0 | 31 | | 2013 | 21 | 2 | 23 | | 2014 | 17 | 3 | 20 | | 2015 | 24 | 7 | 31 | | 2016 | 22 | 3 | 25 | | 2017 | 32 | 4 | 36 | | 2018 | 32 | 3 | 35 | | 2019 | 28 | 2 | 30 | | 2020 | 33 | 5 | 38 | | 2021 | 17 | 2 | 19 | | 2022 | 26 | 0 | 26 | | 2023 | 18 | 0 | 18 | | 2024 | 16 | 9 | 25 | | 2025 | 17 | 2 | 19 | | 2026 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Hwang JC, Huhmann LB, Cho K, Goryachev SD, Starink N, Weinstock MA, Asgari MM, Zheng C, Lu C, Feldman TC, Do NV, Gaziano JM, Semenov YR, Hurlbert MS, Fillmore NR, Hartman RI. Identification of Risk Factors for Acral Melanoma in US Veterans. JAMA Dermatol. 2026 03 01; 162(3):279-291.
-
Schermerhorn SMV, Vore E, Bondoc AJ, Lautz TB, Ayala SA, Kastenberg ZJ, Arkin C, Malek MM, Campwala I, Aldrink JH, Horvath KZ, Piché N, Osman Y, Brown EG, Doyle K, Abril P, Roach JP, Ziogas IA, Rhee DS, Chidiac C, Polites SF, Debertin J, Craig BT, Lal DR, Kim ES, Lee WG, Barkhordar A, Le HD, Joshi D, Stellon M, Tracy ET, Beckhorn C, Davies DA, Boehmer C, Dasgupta R. Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients: A Pediatric Surgical Oncology Research Collaborative prospective observational study. Cancer. 2026 Feb 15; 132(4):e70274.
-
Lorigan P, Medina TM, Nyakas M, Rutten A, Feun LG, Cowey CL, Payne M, Hussain I, Kuzel T, O'Day S, Sheri A, Friedlander PA, Kumar S, Bergersen VS, Foss Ø, Ellingsen EB, Bjørheim J, Bechter OE. The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study. Eur J Cancer. 2026 Jan 17; 233:116162.
-
Chauvel-Picard J, Zahouani H, Tognetti L, Cinott E, Lange E, Suppa M, Rubegni P, Marmol VD, Raffaelli C, Bahadoran P, Perrot JL. Skin ultra-sound: Its history and advances. Ann Dermatol Venereol. 2025 Dec; 152(4):103437.
-
Hitchcock D, Newman S, Pang CS, Raghavan SS. Beyond Classic Leukemia Cutis: Evidence of Leukemic Cell "Spillover". J Cutan Pathol. 2026 Feb; 53(2):180-185.
-
Im C, Boull C, Lu Z, Liao K, Hasan H, Xu L, Sapkota Y, Howell RM, Arnold MA, Conces MR, Housten AJ, Gebauer J, Langer T, Teepen JC, Kremer LCM, Constine LS, Yasui Y, Hudson MM, Ness KK, Armstrong GT, Neglia JP, Yuan Y, Turcotte LM. Basal cell carcinoma risk prediction in survivors of childhood cancer. J Natl Cancer Inst. 2025 Nov 01; 117(11):2352-2361.
-
Klein JC, Shahwan KT, Petric UB, Mallela T, Voller L, Ruiz E, Ran N, Granger EE, Koyfman S, Vidimos A, Wysong A, Hirotsu K, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Brodland DG, Zitelli JA, Willenbrink TJ, Lotter W, Jeanselme V, Nikahd M, Nijhawan RI, Srivastava D, Carr DR. Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes. J Am Acad Dermatol. 2026 Jan; 94(1):151-160.
-
Neff C, Price M, Ballard CAP, Cioffi G, Liu Z, Walsh R, Barnholtz-Sloan JS, Walsh KM, Salama AKS, Anders CK, Fecci PE, Ostrom QT. Atopy Improves Survival and Decreases Risk of Brain Metastasis in Cutaneous Melanoma. Cancer Epidemiol Biomarkers Prev. 2025 Sep 02; 34(9):1600-1608.
-
Hasanov M, Kiany S, Forget MA, Bassett R, Davies MA, Diab A, Gershenwald JE, Glitza IC, Lee JE, Lucci A, McQuade JL, Patel SP, Ross MI, Tawbi HA, Wargo JA, Wong MK, Bernatchez C, Hwu P, Haymaker C, Amaria RN. Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma. Oncoimmunology. 2025 Dec; 14(1):2546402.
-
Tiago M, Purwin TJ, Stefanski CD, da Silva RO, Fane ME, Chhabra Y, Haj JI, Teh JL, Kadamb R, Cai W, Rosenbaum SR, Chua V, Hacohen N, Davies MA, Villanueva J, Chervoneva I, Weeraratna AT, Erkes DA, Capparelli C, Aguirre-Ghiso JA, Aplin AE. Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma. J Clin Invest. 2025 Sep 16; 135(18).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|